Pulmonology Xagena

Xagena Mappa
Xagena Newsletter
Medical Meeting

Search results for "Aclidinium"

Aclidinium bromide ( Eklira, Bretaris ) has been approved since October 2012 for widening the narrowed airways of adults with chronic-obstructive pulmonary disease ( COPD ). The German Institute for Q ...

The ACLIFORM/COPD study has assessed the efficacy and safety of two doses of twice-daily ( BID ) Aclidinium bromide / Formoterol fumarate fixed-dose combination ( FDC ) in patients with moderate-to-se ...

Aclidinium bromide / Formoterol fumarate ( 400/12 mcg ) is a fixed dose combination of two approved long-acting bronchodilators with different mechanisms of action and similar pharmocodynamic profiles ...